Issam Zineh, PharmD, MPH
- 2Articles
- 9.6KReads
- 2011–2012Active
- 22Collaborators
- 106Citations
About
Issam Zineh, PharmD, MPH, has published research on the clinical application of genetic information for guiding pharmacological treatment and the regulatory basis for antidepressant approvals. His work includes studies on CYP2D6 genotype-guided dosing of pimozide in various patient populations and the clinical rationale behind the FDA approval of vilazodone for depression. His publications span topics in major depressive disorder and pharmacogenetics.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
